HUP0004345A3 - Novel oral pharmaceutical compositions containing from carvedilol - Google Patents
Novel oral pharmaceutical compositions containing from carvedilolInfo
- Publication number
- HUP0004345A3 HUP0004345A3 HU0004345A HUP0004345A HUP0004345A3 HU P0004345 A3 HUP0004345 A3 HU P0004345A3 HU 0004345 A HU0004345 A HU 0004345A HU P0004345 A HUP0004345 A HU P0004345A HU P0004345 A3 HUP0004345 A3 HU P0004345A3
- Authority
- HU
- Hungary
- Prior art keywords
- carvedilol
- pharmaceutical compositions
- compositions containing
- oral pharmaceutical
- novel oral
- Prior art date
Links
- NPAKNKYSJIDKMW-UHFFFAOYSA-N carvedilol Chemical compound COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=NC3=CC=C[CH]C3=C12 NPAKNKYSJIDKMW-UHFFFAOYSA-N 0.000 title 1
- 229960004195 carvedilol Drugs 0.000 title 1
- 239000008203 oral pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6545697P | 1997-11-12 | 1997-11-12 | |
| PCT/US1998/024102 WO1999024017A1 (en) | 1997-11-12 | 1998-11-12 | Novel oral dosage form for carvedilol |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0004345A2 HUP0004345A2 (en) | 2001-06-28 |
| HUP0004345A3 true HUP0004345A3 (en) | 2001-10-29 |
Family
ID=22062830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0004345A HUP0004345A3 (en) | 1997-11-12 | 1998-11-12 | Novel oral pharmaceutical compositions containing from carvedilol |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1030651A4 (en) |
| JP (1) | JP2001522794A (en) |
| KR (1) | KR20010031952A (en) |
| CN (1) | CN1285738A (en) |
| AU (1) | AU751117B2 (en) |
| BR (1) | BR9814127A (en) |
| CA (1) | CA2309542A1 (en) |
| HU (1) | HUP0004345A3 (en) |
| IL (1) | IL136028A0 (en) |
| NO (1) | NO20002439L (en) |
| NZ (1) | NZ504418A (en) |
| PL (1) | PL340456A1 (en) |
| TR (1) | TR200001362T2 (en) |
| WO (1) | WO1999024017A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040151772A1 (en) | 2002-11-08 | 2004-08-05 | Egalet A/S | Controlled release carvedilol compositions |
| WO2004056336A2 (en) * | 2002-12-20 | 2004-07-08 | Ranbaxy Laboratories Limited | Controlled release, multiple unit drug delivery systems |
| ES2662903T3 (en) * | 2003-11-25 | 2018-04-10 | Smithkline Beecham (Cork) Limited | Carvedilol-free base, salts, anhydrous or solvate forms thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or administration procedures |
| US20050169994A1 (en) * | 2003-11-25 | 2005-08-04 | Burke Matthew D. | Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods |
| CA2648278C (en) * | 2006-04-03 | 2019-05-28 | Isa Odidi | Drug delivery composition |
| TWI415604B (en) | 2009-09-29 | 2013-11-21 | Tsh Biopharm Corp Ltd | Controlled release carvediolol formulation |
| TW201132646A (en) * | 2010-02-22 | 2011-10-01 | Daiichi Sankyo Co Ltd | Oral solid extended release dosage form |
| ES2706880T3 (en) | 2010-02-22 | 2019-04-01 | Daiichi Sankyo Co Ltd | Sustained-release solid preparation for oral use |
| TW201200165A (en) * | 2010-02-22 | 2012-01-01 | Daiichi Sankyo Co Ltd | Oral solid extended release dosage form |
| KR102127625B1 (en) | 2012-09-03 | 2020-06-29 | 다이이찌 산쿄 가부시키가이샤 | Hydromorphone hydrochloride-containing oral sustained-release pharmaceutical composition |
| KR102158339B1 (en) * | 2016-02-05 | 2020-09-21 | 삼진제약주식회사 | Carvedilol immediate release formulation having improved madescent |
| KR102492147B1 (en) | 2020-12-30 | 2023-01-26 | 단국대학교 천안캠퍼스 산학협력단 | Carvedilol loaded solid oral compositions using self-nanoemulsifying drug delivery system and methods for their preparation |
| KR102525298B1 (en) | 2020-12-30 | 2023-04-25 | 단국대학교 천안캠퍼스 산학협력단 | Carvedilol loaded solid dispersion with increased oral bioavailability and methods for their preparation |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2815926A1 (en) * | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | NEW CARBAZOLYL- (4) -OXY-PROPANOLAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
| JPS5598120A (en) * | 1979-01-16 | 1980-07-25 | Shin Etsu Chem Co Ltd | Preparation of drug having enteric coating |
| CA1146866A (en) * | 1979-07-05 | 1983-05-24 | Yamanouchi Pharmaceutical Co. Ltd. | Process for the production of sustained release pharmaceutical composition of solid medical material |
| US4680323A (en) * | 1983-12-01 | 1987-07-14 | Hans Lowey | Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration |
| ES2082994T3 (en) * | 1990-10-23 | 1996-04-01 | Davband Pty Ltd | BACK SUPPORT FOR A CHAIR OR SEAT. |
| US5760069A (en) * | 1995-02-08 | 1998-06-02 | Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership #1 | Method of treatment for decreasing mortality resulting from congestive heart failure |
| DE19637082A1 (en) * | 1996-09-12 | 1998-03-19 | Boehringer Mannheim Gmbh | Rapidly disintegrating pellets |
-
1998
- 1998-11-12 EP EP98958546A patent/EP1030651A4/en not_active Withdrawn
- 1998-11-12 WO PCT/US1998/024102 patent/WO1999024017A1/en not_active Application Discontinuation
- 1998-11-12 TR TR2000/01362T patent/TR200001362T2/en unknown
- 1998-11-12 NZ NZ504418A patent/NZ504418A/en unknown
- 1998-11-12 CA CA002309542A patent/CA2309542A1/en not_active Abandoned
- 1998-11-12 BR BR9814127-9A patent/BR9814127A/en not_active IP Right Cessation
- 1998-11-12 JP JP2000520110A patent/JP2001522794A/en active Pending
- 1998-11-12 KR KR1020007005059A patent/KR20010031952A/en not_active Application Discontinuation
- 1998-11-12 PL PL98340456A patent/PL340456A1/en unknown
- 1998-11-12 HU HU0004345A patent/HUP0004345A3/en unknown
- 1998-11-12 AU AU14569/99A patent/AU751117B2/en not_active Ceased
- 1998-11-12 IL IL13602898A patent/IL136028A0/en not_active IP Right Cessation
- 1998-11-12 CN CN98813082A patent/CN1285738A/en active Pending
-
2000
- 2000-05-11 NO NO20002439A patent/NO20002439L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU751117B2 (en) | 2002-08-08 |
| HUP0004345A2 (en) | 2001-06-28 |
| TR200001362T2 (en) | 2000-09-21 |
| AU1456999A (en) | 1999-05-31 |
| KR20010031952A (en) | 2001-04-16 |
| CA2309542A1 (en) | 1999-05-20 |
| NZ504418A (en) | 2003-02-28 |
| JP2001522794A (en) | 2001-11-20 |
| EP1030651A1 (en) | 2000-08-30 |
| BR9814127A (en) | 2000-10-03 |
| PL340456A1 (en) | 2001-02-12 |
| NO20002439D0 (en) | 2000-05-11 |
| CN1285738A (en) | 2001-02-28 |
| IL136028A0 (en) | 2001-05-20 |
| EP1030651A4 (en) | 2006-05-31 |
| NO20002439L (en) | 2000-05-11 |
| WO1999024017A1 (en) | 1999-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2341609B (en) | Dental restorative compositions | |
| HUP9903407A3 (en) | Oral pharmaceutical preparation containing ibandronat | |
| GB9727053D0 (en) | Pharmaceutical compositions | |
| PL334100A1 (en) | Cyclosporin containing compositions for oral administration | |
| CY2569B1 (en) | Pharmaceutical compositions | |
| HUP0103924A3 (en) | Oral pharmaceutical compositions containing buprenorphin | |
| HUP0003757A3 (en) | Oral pharmaceutical compositions of levosimendan | |
| HUP0004345A3 (en) | Novel oral pharmaceutical compositions containing from carvedilol | |
| PL338922A1 (en) | Oral compositions | |
| IL133928A0 (en) | Pharmaceutical composition containing peptichemio | |
| HU9500618D0 (en) | Oral pharmaceutical compositions | |
| IL142534A0 (en) | Pharmaceutical compositions containing an antigen-adjuvent | |
| IL131995A0 (en) | Gastric-retained pharmaceutical compositions | |
| ZA9710919B (en) | Pharmaceutical compositions containing N-sulphony-lindole derivatives | |
| GB9723985D0 (en) | Pharmaceutical compositions | |
| GB9726735D0 (en) | Pharmaceutical compositions | |
| HU9700632D0 (en) | Pharmaceutical compositions | |
| ZA974125B (en) | Oral pharmaceutical compositions | |
| HUP0003528A3 (en) | Pharmaceutical compositions containing dihydropolyprenols | |
| GB9921495D0 (en) | Pharmaceutical compositions | |
| IL132784A0 (en) | Pharmaceutical compositions containing dronabinol | |
| GB9711046D0 (en) | Oral pharmaceutical compositions | |
| HUP0101012A3 (en) | Pharmaceutical composition for oral administration | |
| ZA976144B (en) | Oral pharmaceutical compositions | |
| GB9705844D0 (en) | Oral prophyllactic compositions |